Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rottlaender

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 17, 2008
[Risks of non-prescription medication. Clobutinol cough syrup as a recent example]D Rottlaender, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|January 24, 2008
[Natriuretic peptides--when should they be used in heart failure?]D Rottlaender, G Michels, U C Hoppe
Herz|July 31, 2012
[Diagnostics and therapy of heart failure]R Steinacher, D Rottlaender, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|March 19, 2009
[Cardiac contractility modulation: a new option for treating systolic heart failure]D Rottlaender, G Michels, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|October 15, 2009
[Cryothermal energy: a new perspective for interventional therapy of cardiac arrhythmias?]D Rottlaender, L J Motloch, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|January 19, 2007
[Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]D Rottlaender, M Scherner, T Schneider, et al.
Der Internist|July 28, 2011
[New tyrosine kinase and EGFR inhibitors in cancer therapy. Cardiac and skin toxicity as relevant side effects. Part A: heart]D Rottlaender, S Reda, L J Motloch, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Therapy with glitazones--a risk for cardiovascular disease?]D Rottlaender, G Michels, E Erdmann, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|January 17, 2008
[Risks of non-prescription medication. Clobutinol cough syrup as a recent example]D Rottlaender, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|January 24, 2008
[Natriuretic peptides--when should they be used in heart failure?]D Rottlaender, G Michels, U C Hoppe
Herz|July 31, 2012
[Diagnostics and therapy of heart failure]R Steinacher, D Rottlaender, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|March 19, 2009
[Cardiac contractility modulation: a new option for treating systolic heart failure]D Rottlaender, G Michels, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|October 15, 2009
[Cryothermal energy: a new perspective for interventional therapy of cardiac arrhythmias?]D Rottlaender, L J Motloch, U C Hoppe
Deutsche Medizinische Wochenschrift (1946)|January 19, 2007
[Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]D Rottlaender, M Scherner, T Schneider, et al.
Der Internist|July 28, 2011
[New tyrosine kinase and EGFR inhibitors in cancer therapy. Cardiac and skin toxicity as relevant side effects. Part A: heart]D Rottlaender, S Reda, L J Motloch, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Therapy with glitazones--a risk for cardiovascular disease?]D Rottlaender, G Michels, E Erdmann, et al.
Pageof 1